Stockreport

TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance [Yahoo! Finance]

TriSalus Life Sciences, Inc.  (TLSI) 
PDF Reaffirms 2026 Revenue Guidance of $60-62 million Strengthened Balance Sheet with $46 Million Gross Proceeds from Recent Public Offering Hosting Conference Call and [Read more]